8-K: Concentra Exceeds 2025 Guidance, Projects Strong 2026

Concentra Group Holdings Parent, Inc. announced preliminary unaudited financial results for Q4 and full year 2025, exceeding guidance, and provided a strong 2026 outlook.

Summary

• Preliminary Q4 2025 revenue reached $539.1 million, an increase of 15.9% from Q4 2024.
• Preliminary Q4 2025 net income was $36.2 million, up 58.7% from Q4 2024.
• Preliminary Q4 2025 Adjusted EBITDA increased by 22.9% to $95.3 million.
• Preliminary full year 2025 revenue totaled $2,163.4 million, a 13.9% increase from FY 2024.
• Preliminary full year 2025 net income was $172.8 million, a slight increase of 0.6% from FY 2024, primarily due to IPO recapitalization.
• Preliminary full year 2025 Adjusted EBITDA grew by 14.6% to $431.9 million.
• The company exceeded its previously issued guidance for full year 2025.
• Concentra expanded its footprint by adding over 300 locations in 2025, including 76 occupational health centers and 254 onsite health clinics.
• Approximately 1.1 million shares of common stock were repurchased in Q4 2025, totaling $22.4 million.
• For full year 2026, Concentra expects revenue in the range of $2.25 billion to $2.35 billion and Adjusted EBITDA between $450 million and $470 million.
• The 2026 outlook also projects a net leverage ratio of 3.0x or below, free cash flow of $200 million to $225 million, and capital expenditures of $70 million to $80 million.
• The company published its first Investor Book, offering a comprehensive overview of its business and industry.

Sentiment

Score: 8

Explanation: The filing reports strong preliminary financial results for Q4 and full year 2025, exceeding previous guidance, and provides a positive outlook for 2026 with projected growth and deleveraging. The company's expansion, share repurchase program, and resilient business model contribute to a highly positive sentiment.

Positives

• Exceeded previously issued guidance for full year 2025, demonstrating strong operational performance.
• Reported robust revenue growth: Q4 2025 revenue increased 15.9% to $539.1 million, and FY 2025 revenue grew 13.9% to $2,163.4 million.
• Achieved significant net income growth in Q4 2025, rising 58.7% to $36.2 million.
• Delivered strong Adjusted EBITDA growth: Q4 2025 increased 22.9% to $95.3 million, and FY 2025 increased 14.6% to $431.9 million.
• Expanded Adjusted EBITDA margin to 17.7% in Q4 2025 (from 16.7% in Q4 2024) and to 20.0% for FY 2025 (from 19.8% in FY 2024).
• Substantially expanded its operational footprint by adding 76 occupational health centers and 254 onsite health clinics in 2025.
• Increased patient visits per day by 9.0% in Q4 2025 to 51,005 and by 7.7% for FY 2025 to 53,124.
• Improved revenue per visit by 3.1% in Q4 2025 to $149.63 and by 4.3% for FY 2025 to $147.42.
• Generated strong free cash flow of $197.8 million for FY 2025.
• Improved net leverage ratio to approximately 3.4x at the end of FY 2025.
• Initiated a $100 million share repurchase program, repurchasing approximately 1.1 million shares totaling $22.4 million in Q4 2025.
• Provided a positive 2026 business outlook, projecting continued growth in revenue, Adjusted EBITDA, and free cash flow, alongside further deleveraging to 3.0x or below.

Negatives

• Full year 2025 net income growth was minimal at 0.6% ($172.8 million compared to $171.9 million in FY 2024), primarily attributed to IPO recapitalization.
• Net income margin for FY 2025 decreased to 8.0% from 9.0% in FY 2024.
• Capital expenditures increased significantly by 20.9% in Q4 2025 to $20.2 million and by 28.0% for FY 2025 to $82.3 million, which included approximately $15 million of one-time transition capital expenditures for the Nova acquisition.
• Consumer health patient visits experienced a decline of 3.2% in Q4 2025 and 2.5% for FY 2025.

Risks

• Changes in the frequency of work-related injuries and illnesses and other factors influencing demand for services.
• Changes to relationships with employer customers, third-party payors, workers compensation provider networks or employer services networks, including changes in, or failure to comply with, contract terms.
• Impacts of current and future public policy developments and the implementation of new, and possible changes to or evolving interpretations of existing, federal and state laws and regulations, or failure to comply with such laws or regulations or comply on a timely basis.
• Impacts of cost containment initiatives, including changes in reimbursement policies, methodologies or payment rates undertaken by state workers compensation boards or commissions, employer groups, other third-party payors, and others.
• Ability to realize reimbursement increases at rates sufficient to keep pace with the inflation of costs.
• Ability to navigate labor shortages, increased employee turnover or costs, and union activity.
• Ability to compete effectively with other occupational health centers, onsite health clinics at employer worksites, and healthcare providers.
• Impacts of any security breaches, cyberattacks, loss of data, or cybersecurity threats or incidents involving information technology systems, and any failure to comply with legal requirements related to data privacy, interoperability or data protection.
• Impacts of negative publicity, which could result in increased governmental and regulatory scrutiny and possibly adverse regulatory changes.
• Ability to navigate significant legal actions, including with respect to any uninsured liabilities.
• Impacts of litigation and other legal and regulatory proceedings.
• Ability to successfully navigate any future acquisitions.
• Exposure to additional risk due to reliance on third parties in many aspects of the business.
• Ability to manage relationships with Managed PCs.
• Ability to adapt to healthcare technology initiatives.
• Impacts of facility licensure requirements, which may be costly and time-consuming, limiting or delaying operations.
• Ability to adequately protect and enforce intellectual property and other proprietary rights.
• Ability to navigate uncertainty in the healthcare industry.
• Ability to navigate adverse, uncertain economic conditions, both in the United States or globally.
• Impacts of impairment of goodwill and other intangible assets.
• Ability to maintain satisfactory credit ratings.
• Ability to manage the effects of the Separation on the business.
• Ability to achieve the expected benefits of and successfully execute the Separation and related transactions.
• Impacts of restrictions on the business, potential tax and indemnification liabilities and substantial charges in connection with the Separation and related transactions.
• Effects related to pandemics, epidemics, outbreaks of infectious disease, or other public health crises.
• Impacts related to the loss of key members of the management team.
• Ability to attract and retain talented, highly skilled employees and a diverse workforce, and on the succession of senior management.
• Impacts of climate change, or legal, regulatory or market measures to address climate change.
• Ability to navigate increasing scrutiny and rapidly evolving expectations from stakeholders regarding environmental, social, and governmental (ESG) matters.
• Impacts of changes in tax laws or exposures to additional tax liabilities.

Future Outlook

For full year 2026, Concentra expects revenue in the range of $2.25 billion to $2.35 billion, Adjusted EBITDA between $450 million and $470 million, a net leverage ratio of 3.0x or below, free cash flow of $200 million to $225 million, and capital expenditures in the range of $70 million to $80 million. This outlook assumes low single-digit organic visit growth (excluding Nova), approximately 3% rate growth, and includes planned de novo openings and the Reliant acquisition.

Management Comments

• "The 2025 fiscal year was another transformative year for Concentra as we continued to provide superior outcomes and exceptional experience to our patients and customers, all while significantly growing our business."
• "Our excellent performance in 2025 is a testament to our skilled and dedicated colleagues efforts to improve the health of Americas workforce, one patient at a time."
• "With over 300 locations added in 2025, we continue to elevate industry standards of care and further enhance Concentras ongoing efforts to deliver our differentiated value proposition across the United States."
• "We are pleased to share our strong preliminary 2025 results, as well as provide our business outlook for 2026."

Industry Context

Concentra operates in the occupational health services industry, which is experiencing stable growth driven by factors such as an aging workforce, increasing comorbidities leading to more severe injuries, high injury rates among young workers, and the prevalence of depression and anxiety impacting recovery. Reshoring initiatives in U.S. manufacturing, infrastructure, and technology, along with AI-fueled job creation, are creating tailwinds for job growth and construction demand, increasing the need for occupational health services. The industry is fragmented, with Concentra being the largest pure-play provider, treating approximately 1 in 4 workplace injuries in the U.S.

Comparison to Industry Standards

• Concentra is the largest provider of occupational health services in the U.S. by number of locations, more than 10 times the size of its next largest pure-play occupational health competitor.
• Treats approximately 1 in every 4 injuries that occur within the U.S. workplace.
• Achieves 25% average lower cost per claim compared to competitors, based on studies of approximately 500,000 closed claims.
• 95% of injured employees treated are recommended for return to work in some capacity on the same day after initial visit.
• Compared to the industry average, Concentra hires its providers 50% faster.
• Maintained stable margins and resilient performance through the Global Financial Crisis (2007-2009) and the COVID-19 pandemic (2019-2020), with Adjusted EBITDA declining only 6% and 9% respectively during periods of significant visit volume decline (19% and 12%).
• Has grown into the third largest operator of onsite health clinics in the U.S. by number of locations.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, exceeding guidance, share repurchase program, and consistent dividend. Potential for continued share price appreciation based on positive 2026 outlook and deleveraging.
• Employees/Clinicians: Positive impact from a growing business, as the company emphasizes its "skilled and dedicated colleagues" and ability to attract and retain talent.
• Customers (Employers): Continued benefit from superior outcomes, exceptional experience, and differentiated value proposition, including lower claim costs and shorter claim durations. Expanded footprint provides greater access to services.
• Patients: Benefit from improved health outcomes and exceptional experience, as stated by the CEO.

Next Steps

• Issue full fourth quarter and fiscal year 2025 financial results on February 26, 2026.
• Host a conference call on February 27, 2026, regarding 2025 financial results and 2026 business outlook.
• Continue strategic investment in technology, facilities, and infrastructure.
• Pursue a strong pipeline of bolt-on acquisitions and de novos.
• Maintain a quarterly cash dividend of $0.0625 per share.
• Continue the authorized $100 million share repurchase program.
• Focus on de-levering to 3.0x net leverage by the end of 2026.

Key Dates

Recommendation

Concentra has demonstrated robust financial performance, exceeding its 2025 guidance with significant revenue and Adjusted EBITDA growth. The company's strategic expansion through acquisitions and de novos, coupled with strong free cash flow generation and a commitment to deleveraging, positions it for continued success. The positive 2026 outlook, including projected growth in key metrics and a target net leverage ratio of 3.0x or below, indicates strong future prospects. The share repurchase program and consistent dividend further enhance shareholder value. Given the industry leadership, resilient business model, and clear growth trajectory, Concentra represents a compelling investment opportunity.

Keywords

Occupational health, Onsite health clinics, Workers compensation, Employer services, Healthcare, Medical services, Urgent care, Physical therapy, Telemedicine, M&A, De novos, Financial results, Guidance, SEC filing